We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

48 hedge funds and large institutions have $84.8M invested in Tenax Therapeutics in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

136% more capital invested

Capital invested by funds: $35.9M → $84.8M (+$48.9M)

41% more funds holding

Funds holding: 34 → 48 (+14)

8.03% more ownership

Funds ownership: 103.47% → 111.5% (+8%)

Holders
48
Holders Change
+14
Holders Change %
+41.18%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
12
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$3.82M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.68M
3
Morgan Stanley
Morgan Stanley
New York
+$3.64M
4
DP
Diadema Partners
New Jersey
+$2.12M
5
SFM
Sphera Funds Management
Israel
+$1.65M

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$3.33M
2
Millennium Management
Millennium Management
New York
-$97.8K
3
VF
Virtu Financial
New York
-$92K
4
DS
DRW Securities
Illinois
-$80K
5
TRCT
Tower Research Capital (TRC)
New York
-$2.63K
Name Holding Trade Value Shares
Change 		Change in
Stake
VPC
26
Vestal Point Capital
New York
$651K – – –
BCM
27
Bridgeway Capital Management
Texas
$547K +$391K +44,900 New
AGP
28
Artia Global Partners
Florida
$513K +$366K +42,080 New
Two Sigma Investments
29
Two Sigma Investments
New York
$408K +$291K +33,470 New
Corient Private Wealth
30
Corient Private Wealth
Florida
$302K +$215K +24,776 New
Goldman Sachs
31
Goldman Sachs
New York
$273K +$195K +22,409 New
QC
32
Quadrature Capital
United Kingdom
$252K +$180K +20,648 New
BlackRock
33
BlackRock
New York
$204K +$143K +16,413 +5,453%
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$186K +$133K +15,296 New
Two Sigma Advisers
35
Two Sigma Advisers
New York
$161K +$115K +13,178 New
SCM
36
Stonepine Capital Management
Oregon
$145K +$103K +11,884 New
LBA
37
Letko, Brosseau & Associates
Quebec, Canada
$130K +$92.6K +10,650 New
Bank of America
38
Bank of America
North Carolina
$46.1K +$30.7K +3,526 +1,388%
JP Morgan Chase
39
JP Morgan Chase
New York
$11K +$7.84K +902 New
UBS Group
40
UBS Group
Switzerland
$8.24K +$4.84K +557 +468%
TRCT
41
Tower Research Capital (TRC)
New York
$2.43K -$2.63K -302 -60%
AF
42
Allworth Financial
California
$13 – – –
PWA
43
Physician Wealth Advisors
Utah
$13 – – –
Rockefeller Capital Management
44
Rockefeller Capital Management
New York
$12 -$9 -1 -50%
Jones Financial Companies
45
Jones Financial Companies
Missouri
$12 – – –
Citigroup
46
Citigroup
New York
$12 +$9 +1 New
TY
47
Titiun Yejiel
$12 +$9 +1 New
UBP
48
Union Bancaire Privee
Switzerland
$9 – – –
VA
49
VR Adviser
New York
– -$3.33M -437,708 Closed
VF
50
Virtu Financial
New York
– -$92K -12,119 Closed
1
2
3

TENX Hedge Fund Activity: Q4 2025 in Review

48 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2025, worth a combined $84.8M — up 136% from $35.9M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TENX positions and 5 closed out — a net gain of 14 holders — while 12 added to existing stakes and 3 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $3.82M. The largest seller was VR Adviser, exiting entirely with an estimated $3.33M sold.

  • 48 institutional investors held Tenax Therapeutics (TENX) as of Q4 2025, up from 34 in Q3 2025.
  • Funds reported $84.8M of Tenax Therapeutics stock for Q4 2025, up 136% quarter-over-quarter.
  • 19 funds opened new Tenax Therapeutics positions in Q4 2025 and 5 closed out, a net change of +14 holders.
  • The largest Tenax Therapeutics buyer in Q4 2025 was Perceptive Advisors, an estimated $3.82M added.
  • The largest Tenax Therapeutics seller in Q4 2025 was VR Adviser, an estimated $3.33M sold.

Based on aggregated 13F filings for Q4 2025.